This is a working overview of GIP receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-01-01 and is reviewed periodically as new material appears.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 39-residue peptide | GIP-derived backbone with non-natural residues |
| Molar mass | Approximately 4.8 kDa | Peptide chain plus linker and lipid modifications |
| Appearance | White to off-white powder | Typical of lyophilized research material |
| Solubility | Soluble in water and aqueous buffer | Practically insoluble in nonpolar solvents |
| Storage temperature | Typically −20 °C for dry powder | Solutions usually held at 2–8 °C short term |
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Tirzepatide 是一种由 39 个氨基酸组成的合成肽，分子结构上以 GIP 序列为骨架并引入脂肪酸侧链修饰，使其能够同时与葡萄糖依赖性促胰岛素多肽（GIP）受体和胰高血糖素样肽-1（GLP-1）受体结合。这种双重激动特性使它在同类肽类药物中区别于选择性 GLP-1 受体激动剂。该分子最早由一家制药公司在 2010 年代报道，随后进入糖尿病与体重管理领域的临床研究。
在生理层面，GIP 与 GLP-1 均为肠道内分泌细胞分泌的肠促胰素，进食后参与胰岛素分泌调节与胃排空抑制。Tirzepatide 通过同时激活这两条信号通路，使胰岛素分泌的葡萄糖依赖性增强，并延缓冲胃排空、降低食欲信号。与单一 GLP-1 激动相比，双靶点作用在血糖控制和体重变化上的效应幅度更大，但具体贡献比例仍在研究之中。
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Degradation to tetranorlipoic acid in which the four CH2-groups between the ring and the carboxilic acid are removed, oxidation of one or both of the sulfur atoms to the sulfoxide, and S-methylation of the sulfide occur. Degradation of lipoic acid is similar in humans, although it is not clear if the sulfur atoms become significantly oxidized.
== α-Ketoglutarates: glutamate, glutamine, proline, arginine == Most amino acids are synthesized from α-ketoacids, and later transaminated from another amino acid, usually glutamate. The enzyme involved in this reaction is an aminotransferase.
This function shares the same values for its term in common with the Kármán–Prandtl resistance equation, plus one parameter 0.305 or 0.34 to fit the asymptotic behavior for R∗ → ∞ along with one further parameter, 26, to govern the transition from smooth to rough flow.
Cuprates are layered materials, consisting of superconducting planes of copper oxide, separated by layers containing ions such as lanthanum, barium, strontium, which act as a charge reservoir, doping electrons or holes into the copper-oxide planes. Thus the structure is described as a superlattice of superconducting CuO2 layers separated by spacer layers, resulting in a structure often closely related to the perovskite structure. Superconductivity takes place within the copper-oxide (CuO2) sheets, with only weak coupling between adjacent CuO2 planes, making the properties close to that of a two-dimensional material. Electrical currents flow within the CuO2 sheets, resulting in a large anisotropy in normal conducting and superconducting properties, with a much higher conductivity parallel to the CuO2 plane than in the perpendicular direction. Critical superconducting temperatures depend on the chemical compositions, cations substitutions and oxygen content. Chemical formulae of superconducting materials generally contain fractional numbers to describe the doping required for superconductivity. There are several families of cuprate superconductors which can be categorized by the elements they contain and the number of adjacent copper-oxide layers in each superconducting block. For example, YBCO and BSCCO can alternatively be referred to as Y123 and Bi2201/Bi2212/Bi2223 depending on the number of layers in each superconducting block (n).
Sources: en.wikipedia.org
The mould needs air to grow, so cultivation required a container with a large surface area. Initially, glass bottles laid on their sides were used. Most laboratory containers did not provide a large, flat area, and so were an uneconomical use of incubator space. The bedpan was found to be practical, and was the basis for specially-made ceramic containers fabricated by J. Macintyre and Company in Burslem. These containers were rectangular in shape and could be stacked to save space. The MRC agreed to Florey's request for £300 (equivalent to £15,000 in 2025) and £2 each per week (equivalent to £97 in 2025) for two women factory hands. In 1943 Florey asked for their wages to be increased to £2 10s each per week (equivalent to £99 in 2025). Heatley collected the first 174 of an order for 500 vessels on 22 December 1940, and they were seeded with spores three days later. Efforts were made to coax the mould into producing more penicillin. Heatley tried adding various substances to the medium, including sugars, salts, malts, alcohol and even marmite, without success. At the suggestion of Paul Fildes, he tried adding brewing yeast. This did not improve the yield either, but it did cut the incubation time by a third. The team also discovered that if the penicillin-bearing fluid was removed and replaced by fresh fluid, a second batch of penicillin could be prepared, but this practice was discontinued after eighteen months due to the danger of contamination. The mould had to be grown under sterile conditions.
Food chains are often used in ecological modeling (such as a three-species food chain). They are simplified abstractions of real food webs, but complex in their dynamics and mathematical implications. In its simplest form, the length of a chain is the number of links between a trophic consumer and the base of the web. The mean chain length of an entire web is the arithmetic average of the lengths of all chains in the food web. The food chain is an energy source diagram. The food chain begins with a producer, which is eaten by a primary consumer. The primary consumer may be eaten by a secondary consumer, which in turn may be consumed by a tertiary consumer. The tertiary consumers may sometimes become prey to the top predators known as the quaternary consumers. For example, a food chain might start with a green plant as the producer, which is eaten by a snail, the primary consumer. The snail might then be the prey of a secondary consumer such as a frog, which itself may be eaten by a tertiary consumer such as a snake which in turn may be consumed by an eagle. This simple view of a food chain with fixed trophic levels within a species: species A is eaten by species B, B is eaten by C, ... is often contrasted by the real situation in which the juveniles of a species belong to a lower trophic level than the adults, a situation more often seen in aquatic and amphibious environments, e.g., in insects and fishes. This complexity was denominated metaphoetesis by G. E. Hutchinson, 1959.
Soils contaminated with zinc from mining, refining, or fertilizing with zinc-bearing sludge can contain several grams of zinc per kilogram of dry soil. Levels of zinc in excess of 500 ppm in soil interfere with the ability of plants to absorb other essential metals, such as iron and manganese. Zinc levels of 2000 ppm to 180,000 ppm (18%) have been recorded in some soil samples.
Similarly, the farmer populations worked the system of collective farms to grow food to feed the industrial workers in the industrialised cities. Since the mid-1930s, Marxism–Leninism has advocated an austere social-equality based upon asceticism, egalitarianism, and self-sacrifice. In the 1920s, the Bolshevik party semi-officially allowed some limited, small-scale wage inequality to boost labour productivity in the economy of the Soviet Union. These reforms were promoted to encourage materialism and acquisitiveness in order to stimulate economic growth. This pro-consumerist policy has been advanced on the lines of industrial pragmatism as it advances economic progress through bolstering industrialisation. In the economic praxis of Bolshevik Russia, there was a defining difference of political economy between socialism and communism. Lenin explained their conceptual similarity to Marx's descriptions of the lower-stage and the upper-stage of economic development, namely that immediately after a proletarian revolution in the socialist lower-stage society the practical economy must be based upon the individual labour contributed by men and women, and paid labour would be the basis of the communist upper-stage society that has realised the social precept of the slogan "From each according to his ability, to each according to his needs."
Academy players to be nominated by 15 September. With a bidding process held on 24 November along with father–son selections during the national draft. The free agency offer period; held between 9 October and 18 October. Three further free agency periods are held for delisted players, between 31 October and 9 November, 11 November to 20 November, and 25 November to 26 November. The trade period; held between 12 October and 22 October. The 2015 national draft; held on 24 November at the Adelaide Convention Centre, which, for the first time, included live bidding for academy and father-son selections. The 2016 pre-season draft; which was to be held on 27 November, but was cancelled when all clubs declined to take part, and The 2016 rookie draft; which was held on 27 November. Additionally, following the guilty verdicts handed down to 34 past and present Essendon players in January 2016 for doping violations, Essendon was given the opportunity to recruit top-up players between January and March 2016.
Sources: en.wikipedia.org
Antibody - targets the cancer cell surface and may also elicit a therapeutic response. Payload - elicits the desired therapeutic response. Linker - attaches the payload to the antibody and should be stable in circulation only releasing the payload at the desired target. Multiple approaches to conjugation have been developed for attachment to the antibody and reviewed. DAR is the drug to antibody ratio and indicates the level of loading of the payload on the ADC.
=== Alkenes === Alkenes often produce stronger molecular ion peaks than alkanes due to the lower ionization energy of a pi electron than a σ electron. After the ionization, double bonds can migrate easily, resulting in almost impossible determination of isomers. Allylic cleavage is most significant fragmentation mode due to resonance stabilization.
== History == Ecotutu is a Nigerian cleantech company focused on preserving fruits and vegetables in developing countries. It was founded in 2020 by Babajide Oluwase and Michael Akinsete. In 2021, Ecotutu was listed among ten finalists for the United Nations World Food Programme (WFP). In 2022, the company was named among the top three finalists at Global Entrepreneurship Summit and won the Zenith Bank FutureForward Tech Fair securing N20 million prize money.
=== March === March 28, 2013: Cyprus Banks in Cyprus re-open after having been closed for two weeks. The government of Cyprus agrees a 10 billion euro bailout deal with the EU and IMF. Depositors with more than € 100,000 in certain banks will lose up to 60% of their deposits. An earlier proposal that would have seen depositors with less than €100,000 losing 6.75% of their deposits fails to attract a single vote in favor in the Cypriot parliament. Russia is expected to help finance the bailout by delaying the repayment of a 2.5 billion euro loan to Cyprus until 2021.
Sources: en.wikipedia.org
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.
It is given by subcutaneous injection, generally on a weekly schedule. Dosing usually begins low and increases in steps to limit gastrointestinal side effects. Formulated product is supplied as a ready-to-use pen or vial in most markets.
No. Receptor engagement is documented, but how central appetite circuits, gut signals, and insulinotropic effects combine is incompletely resolved. Investigators continue to separate GIP-driven from GLP-1-driven contributions in animal and human models.
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.